Literature DB >> 9025784

Use of bisphosphonates in cancer patients.

J J Body1, R E Coleman, M Piccart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9025784     DOI： 10.1016/s0305-7372(96)90020-1

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  17 in total

Review 1.  Metastatic bone cancer pain: etiology and treatment options.

Authors:  Gary C O'Toole; Patrick Boland
Journal:  Curr Pain Headache Rep       Date:  2006-08

Review 2.  Recent advances: oncology.

Authors:  M H Tattersall; H Thomas
Journal:  BMJ       Date:  1999-02-13

Review 3.  Clodronate: a review of its use in breast cancer.

Authors:  M Hurst; S Noble
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 4.  Zoledronic acid.

Authors:  S M Cheer; S Noble
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Bisphosphonates in the treatment of metastatic breast cancer.

Authors:  J J Body
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

6.  Effects of two administration schemes of intramuscular clodronic acid on bone mineral density: a randomized, open-label, parallel-group study.

Authors:  Bruno Frediani
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

7.  Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.

Authors:  Bruno Frediani; Ilaria Bertoldi; Serena Pierguidi; Antonella Nicosia; Valentina Picerno; Georgios Filippou; Luca Cantarini; Mauro Galeazzi
Journal:  Clin Drug Investig       Date:  2013-03       Impact factor: 2.859

8.  A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid.

Authors:  Carlo C Quattrocchi; Daniele Santini; Paola Dell'aia; Sara Piciucchi; Emanuele Leoncini; Bruno Vincenzi; Rosario Francesco Grasso; Giuseppe Tonini; Bruno Beomonte Zobel
Journal:  Skeletal Radiol       Date:  2007-10-03       Impact factor: 2.199

Review 9.  Clodronic acid formulations available in Europe and their use in osteoporosis: a review.

Authors:  Bruno Frediani; Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 10.  Clodronate: new directions of use.

Authors:  Bruno Frediani; Ilaria Bertoldi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.